Growth Metrics

Baxter International (BAX) Change in Accured Expenses (2016 - 2025)

Baxter International (BAX) has disclosed Change in Accured Expenses for 17 consecutive years, with $180.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 221.62% to $180.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $149.0 million, a 238.64% increase, with the full-year FY2025 number at $149.0 million, up 238.64% from a year prior.
  • Change in Accured Expenses was $180.0 million for Q4 2025 at Baxter International, up from -$182.0 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $554.0 million in Q4 2023 to a low of -$396.0 million in Q4 2022.
  • A 5-year average of $26.8 million and a median of -$4.5 million in 2022 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: plummeted 397.06% in 2023, then soared 301.68% in 2024.
  • Baxter International's Change in Accured Expenses stood at $298.0 million in 2021, then crashed by 232.89% to -$396.0 million in 2022, then skyrocketed by 239.9% to $554.0 million in 2023, then tumbled by 126.71% to -$148.0 million in 2024, then soared by 221.62% to $180.0 million in 2025.
  • Per Business Quant, the three most recent readings for BAX's Change in Accured Expenses are $180.0 million (Q4 2025), -$182.0 million (Q3 2025), and $8.0 million (Q2 2025).